17:02 EDT Aerovate Therapeutics files $350M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTE:
- Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference
- Aerovate Therapeutics reports Q1 EPS (83c), consensus (76c)
- Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
- AVTE Upcoming Earnings Report: What to Expect?
- Two new option listings on May 1st